Related Experiment Video
Updated: Jun 27, 2026
08:14
Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)
Published on: May 4, 2017
Computational Simulation and Experimental Validation of Electric Field Distribution Patterns in TTFields Therapy for
Kairan Zhang1,2, Sheng Chen3, Mengxuan Zheng2,4
1College of Electrical Engineering, Zhejiang University, Hangzhou, Zhejiang, China.
Bioelectromagnetics
|June 26, 2026
Summary
Tumor Treating Fields (TTFields) optimize non-small cell lung cancer treatment using personalized anatomical models and validated simulations. This approach ensures effective electric field delivery for improved therapeutic outcomes.
Area of Science:
- Bioelectromagnetics
- Computational Modeling
- Medical Physics
Background:
- Tumor Treating Fields (TTFields) disrupt cancer cell division using electric fields.
- Achieving therapeutic electric field thresholds in NSCLC is challenging due to thoracic anatomy and tissue heterogeneity.
- Current TTFields delivery methods require optimization for effective NSCLC treatment.
Purpose of the Study:
- To optimize TTFields delivery for non-small cell lung cancer (NSCLC) using high-fidelity anatomical models and validated simulations.
- To enhance electric field coverage in the thoracic region for improved therapeutic efficacy.
- To establish a reliable computational framework for individualized NSCLC treatment planning.
Main Methods:
- Full-wave electromagnetic simulations using high-fidelity male (Duke) and female (Ella) anatomical models.
- Coordinated deployment of orthogonal transducer arrays (AP-20, LR-20, LR-13) with sex-specific tuning.
- In vivo murine measurements to validate simulation results and assess system-level losses.
- Introduction of a correction factor (Roi) to account for voltage delivery variations.
Main Results:
- Optimized transducer arrays and sex-specific tuning significantly improved electric field coverage in the lower and lateral lung regions.
- Simulated configurations demonstrated robustness against variations in lung dielectric parameters.
- In vivo validation confirmed high agreement with simulated data, verifying the computational framework's reliability.
- Calculated electrode-skin current density remained below safety limits, mitigating thermal and stimulation risks.
Conclusions:
- The optimized TTFields strategy, integrating bioelectromagnetic modeling and preclinical validation, provides a reliable method for individualized NSCLC treatment planning.
- This approach enhances therapeutic electric field delivery, offering a complementary physical modality for NSCLC management.
- The validated computational framework serves as a crucial reference for optimizing TTFields therapy in NSCLC patients.
